免疫细胞储存

Search documents
中基长寿科学(00767)拟收购亚洲综合细胞库100%股权
智通财经网· 2025-08-04 12:12
Group 1 - The company, Zhongji Changshou Science (00767), has signed a non-binding memorandum of understanding to acquire 100% equity of the target company, Comprehensive Cell Bank Limited, from China International Orthopedic Medical Group Limited [1] - The target company specializes in cell therapy, cell drug research and development, and health longevity management services, holding the Comprehensive Cell Bank [1] Group 2 - Comprehensive Cell Bank is the world's largest international autologous immune cell bank and is recognized for meeting various international standards, including FDA, AABB, and PIC/S cGMP [2] - It is the only clinical cell bank in Asia registered with the FDA for both immune cells and stem cells, ensuring compliance with international standards for cell management [2] Group 3 - The Comprehensive Cell Bank began operations on November 17, 2018, and possesses patented technologies in cancer early screening, NK cells, stem cells, and cartilage cells, along with 22 advanced medical testing platforms [3] - The company can provide services to 300,000 people globally, with potential revenue exceeding HKD 30 billion from immune cell storage, cancer early screening, longevity medical testing, and related cell therapies [3]
中基长寿科学拟收购亚洲综合细胞库100%股权
Zhi Tong Cai Jing· 2025-08-04 12:11
Group 1 - The company, Zhongji Changshou Science (00767), has signed a non-binding memorandum of understanding to acquire 100% equity of the target company, Comprehensive Cell Bank Limited, from China International Orthopedic Medical Group Limited [1] - The target company specializes in cell therapy, cell drug research and development, and health longevity management services, holding the Comprehensive Cell Bank [1] Group 2 - Comprehensive Cell Bank is the largest international autologous immune cell bank in the world and is recognized for meeting various international standards, including FDA, AABB, and PIC/S cGMP [2] - The bank addresses the global challenge of insufficient international standard cell quantities and ensures safe and effective applications, positioning itself as a leading international cell transformation application platform [2] Group 3 - Since its operation began on November 17, 2018, the Comprehensive Cell Bank has developed patented technologies in cancer early screening, NK cells, stem cells, and chondrocytes, and operates 22 advanced medical testing platforms [3] - The bank can provide services to 300,000 people globally, focusing on immune cell storage, cancer early screening, longevity medical testing, and cell therapy research and development, with potential revenue exceeding HKD 30 billion [3]
中基长寿科学(00767.HK)拟收购亚洲综合细胞库100%股权
Ge Long Hui· 2025-08-04 12:05
Group 1 - The company, Zhongji Changshou Science (00767.HK), has signed a non-binding memorandum of understanding to acquire 100% equity of the target company, Comprehensive Cell Bank Limited, from China International Orthopedic Medical Group Limited [1] - The target company specializes in cell therapy, cell drug research and development, and health longevity management services, holding the largest international autologous immune cell bank in the world [1][2] - Comprehensive Cell Bank is recognized as the only FDA, AABB, PIC/S cGMP, ISBER-IRL, FACT, CAP, and ISBT 128 compliant international clinical cell bank, addressing the global shortage of standard cells and ensuring safe and effective applications [1][2] Group 2 - The Comprehensive Cell Bank is the only FDA-registered immune cell and stem cell bank in Asia, meeting international standards for cell management and storage [2] - The facility, located in Hong Kong, has been operational since November 17, 2018, and possesses patented technologies for cancer early screening, NK cells, stem cells, and chondrocytes, along with 22 advanced medical testing platforms [2] - The target company aims to provide services to over 300,000 individuals globally, with potential revenue exceeding HKD 30 billion from its offerings in immune cell storage, cancer early screening, longevity medical testing, and related cell therapies [2]